Statistics

Total Visits

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study.44

Select a period of time:

Number of views in the range

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study.32

Views

Views
January 20259
February 20254
March 202514
April 20252
May 20250
June 20253
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore14
United Kingdom8
United States4
Brazil2
United Arab Emirates2
Germany1
Spain1
 

Top cities views

Views
London2
Council Bluffs1
Munich1
Pedra Preta1
Salto1
Scottsdale1
Suffern1